Bibliography
- Manuel DG , LimJ, TanuseputroPet al.: Revisiting Rose: strategies for reducing coronary heart disease. Br. Med. J., 332(7542), 659–662 (2006).
- Woodward M , BrindleP, Tunstall-Pedoe H; SIGN group on risk estimation: Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart, 93(2), 172–176 (2007).
- Hippisley-Cox J , CouplandC, Vinogradova Y, Robson J, May M, Brindle P: Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. Br. Med. J., 335, 136–148 (2007).
- Wonderling D , McDermottC, BuxtonMet al.: Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. Br. Med. J., 312(7041), 1269–1273 (1996).
- Langham S , ThorogoodM, NormandC, MuirJ, JonesL, FowlerG: Costs and cost effectiveness of health checks conducted by nurses in primary care: the OxCheck study.Br. Med. J., 312(7041), 1265–1268 (1996).
- Marshall T : Evaluating national guidelines for prevention of cardiovascular disease in primary care.J. Eval. Clin. Pract., 11(5), 452–461 (2005).
- The Strategy of Preventive Medicine. Rose GA (Ed.). Oxford University Press, Oxford, UK (1992).
- Rafter N , ConnorJ, HallJet al.: Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk. N Z Med. J., 118(1223), U1676 (2005).
- Camisasca P , AvanziniF, AlliC, ColomboF, TognoniG: Overall cardiovascular risk still ignored in general practice care of hypertension.J. Cardiovasc. Risk, 9(3), 147–152 (2002).
- Chow CK , PellACH, WalkerA, O‘DowdC, DominiczakAF, PellJP: Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.Br. Med. J., 335, 481–485 (2007).
- Pearson TA , BlairSN, DanielsSRet al.: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update: Consensus Panel Guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation, 106(3), 388–391 (2002).
- Pyorala K , De Backer G, Graham I, Poole-Wilson P, Wood D: Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis, 110(2), 121–161 (1994).
- Wood D , De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K: Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other societies on coronary prevention. J. Hypertens., 16(10), 1407–1414 (1998).
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA, 269(23), 3015–3023 (1993).
- Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur. Heart J., 19(10), 1434–1503 (1998).
Websites
- British Heart Foundation. Coronary heart disease statistics 2007. www.heartstats.org/datapage.asp?id=6799
- Department of Health. Health Survey for England. www.dh.gov.uk/en/Publicationsandstatistics/PublishedSurvey/HealthSurveyForEngland/index.htm
- Scottish Government. Scottish health survey. www.scotland.gov.uk/Publications/2005/11/25145024/50251